Dexcom reaffirms full-year forecast after topping quarterly estimates

Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for ...
Business Wire

Dexcom Smart Basal Receives FDA Clearance Becoming the First and Only CGM-integrated Basal Insulin Dosing Optimizer for Type 2 Diabetes

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers. * Dexcom Smart Basal is FDA cleared and now the ...
Medscape

New Dexcom G7 Feature Cleared as 15-day Sensor Set to Launch

The US FDA has cleared a new “basal insulin dose optimizer” function for the Dexcom G7 15-day continuous glucose monitor (CGM), which is set to launch separately on December 1, 2025. The “Smart Basal” ...
The Charlotte Post

Charlotte obesity doctor guides through wearable tech

Wearable technology makes it easier to track health metrics. Ask Dr. Denise Dennis-Coke about health-tracking devices, and she’ll show you the ones she’s wearing. “I have on my Dexcom Stelo, my Oura ...

Demand for Better In-Home Patient Monitoring to Drive 170 Million Smart Home Healthcare Shipments by 2030

The smart home healthcare device segment continues to demonstrate strong growth opportunities. According to ABI Research, total shipments will increase from 124 million units in 2026 to 170 million by ...
Nasdaq

DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal

DexCom DXCM recently announced that it has received FDA clearance for its CGM-integrated basal insulin dosing optimizer, Dexcom Smart Basal, for use by adults with Type 2 diabetes on glargine U-100 ...

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom

They offer investors very different value propositions.